ResMed Surges to 371st in Trading Volume with $235 Million Day Despite Stock Decline

On March 25, 2025, ResMed (RMD) experienced a significant trading volume of $235 million, marking a 39.97% increase from the previous day. This surge placed ResMed at the 371st position in terms of trading volume for the day. However, despite the high trading volume, the stock price of ResMed closed at $222.085, reflecting a 0.73% decrease.

Analysts have given ResMed a consensus rating of "Buy," with an average price target of $249.56 over the next 12 months. This forecast represents a potential increase of 12.35% from the current stock price. The company's stock has a price-to-earnings (P/E) ratio and price/earnings-to-growth (PEG) ratio, which are crucial metrics for evaluating its financial health and growth prospects.

ResMed's stock performance has been notable, with a 52-week high of $262.98 and a 52-week low of $172.19. The company's financial ratios, including a debt-to-equity ratio of 0.13 and a current ratio of 3.33, indicate a strong financial position. Additionally, ResMed's market capitalization stands at A$51.55 billion, making it one of the world's most valuable companies by market cap.